The Lancet Neurology
Fecha de publicación: 1 December 2017
DOI: http://dx.doi.org/10.1016/S1474-4422(17)30403-9
Autores: Raul Martínez-Fernández, MD, Rafael Rodríguez-Rojas, MsC, Marta del Álamo, MD
, Frida Hernández-Fernández, MsC, Jose A Pineda-Pardo, PhD, Michele Dileone, MD, Fernando Alonso-Frech, MD, Guglielmo Foffani, PhD, Ignacio Obeso, PhD, Carmen Gasca-Salas, MD, Esther de Luis-Pastor, MD, Lydia Vela, MD, Prof José A Obeso, MD
Objective: Ablative neurosurgery has been used to treat Parkinson’s disease for many decades. MRI-guided focused ultrasound allows focal lesions to be made in deep brain structures without skull incision. We investigated the safety and preliminary efficacy of unilateral subthalamotomy by focused ultrasound in Parkinson’s disease.
